Menu

ISTOCK, STEINPHOTO

Proposed EPA “Transparency” Rule Criticized

Opponents of the guidelines, which would bar results of many public health studies from use in policy making, include scientific and healthcare organizations.

Jul 18, 2018
Shawna Williams

A proposed rule purportedly aimed at strengthening the transparency of the Environmental Protection Agency’s decision-making process would gut environmental regulations that protect human health, critics argued at a public hearing yesterday at the EPA (July 17). The rule would require that the data underlying any studies used to craft the agency’s policies be publicly available—a bar that would be impossible to reach for many public health studies that rely on confidential health information.

“This would have chilling consequences for the EPA and every person who benefits from clean air and clean water. . . . This proposed rule is an administrative attempt to circumvent the legislative process,” testified US Representative Suzanne Bonamici (D-OR).

See “EPA Seeks to Restrict the Science Used in Policymaking

According to The Atlantic, the guidelines, proposed in April, appear to target regulations that limit particulate air pollution. They are backed by a 1993 study showing that Americans living in cities with higher particulate levels suffered health consequences. That study was the “biggest science fraud that has gone on in this country’s history,” Steven Milloy of the conservative Heartland Institute tells The Atlantic

Other backers of the rule include members of industry trade groups, the Associated Press reports, but critics outnumbered supporters at yesterday’s hearing. The proposal has also drawn opposition from the editors of scientific journals and dozens of public health, medical, academic, and scientific groups.

“If the EPA wanted to engage in a good-faith discussion in how to improve transparency, that’s certainly something they could have done,” Jeremy Berg, the editor-in-chief of Science, tells The Atlantic. “But this doesn’t seem to be that.” 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!